ORAL BIOLOGICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objective and Assumption

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Drug Class
     • Market Snippet, By Disease Indication
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
     • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Recent Test Launches
   • Epidemiology
   • Merger, Acquisition, and Collaborations
   • Regulatory Scenario
   • Key Developments
   • PEST Analysis

4. Global Oral Biologics Market, By Drug Class, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • Glucagon-like Peptide 1 (GLP-1) Receptor Agonist
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Hormone
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Recombinant Enzyme
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Guanylate Cyclase-C Agonist
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Somatostatin Analogue
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends

5. Global Oral Biologics Market, By Disease Indication, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • Diabetes
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Hyperoxaluria
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Acromegaly
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Irritable Bowel Syndrome (IBS) & Chronic Idiopathic Constipation (CIC)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends
   • Others (Inflammatory Bowel Disease (IBD), Hypoparathyroidism, and Others)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
     • Segment Trends

6. Global Oral Biologics Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Oral Biologics Market, By Region, 2021 - 2033, (US$ Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022-2033
     • Segment Trends
   • North America
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (US$ Bn)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast,Y-o-Y Growth and By Drug Class, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, Y-o-Y Growth and By Disease Indication, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (US$ Bn)
     • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region,  2021 - 2033, (US$ Bn)
       • North Africa
       • Central Africa
       • South Africa

8. Competitive Landscape

   • Company Profiles
     • Novo Nordisk A/S
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Biocon Limited
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Oramed Pharmaceuticals, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Rani Therapeutics
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Entera Bio Ltd.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • AbbVie Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Enteris BioPharma, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Chiasma, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies
     • Allena Pharmaceuticals, Inc.
       • Company Overview
       • Product Portfolio
       • Key Highlights
       • Financial Overview
       • Strategies

9. Section

   • References
   • Research Methodology
   • About us and Sales Contact

*Browse 30 market data tables and 26 figures on “Global Oral Biologics Market”-Global forecast to 2033